View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, May 2 (HealthDay News) -- A new test, based on single-nucleotide polymorphisms, that only requires a maternal blood sample can correctly identify paternity as early as 8 weeks' gestation, according to a letter published in the May 3 issue of the New England Journal of Medicine.
Xin Guo, Ph.D., from Ravgen in Columbia, Md., and colleagues collected blood samples from 30 pregnant women at 8 to 14 weeks' gestation and compared the genetic profile of fetal DNA in maternal blood with two samples of blood: one from the biological father and one sample from an unrelated man. To prevent the release of maternal DNA into the plasma, a fixative was added to the maternal blood samples. Use of single-nucleotide polymorphisms to distinguish fetal DNA from maternal DNA allowed short amplicons to be utilized, thereby minimizing allele dropout. For each pregnant woman, the three samples were processed in a blinded fashion.
The researchers found that the test correctly identified the father in all 30 cases. They note that the probability of identifying all 30 fathers correctly was less than one in a billion.
"Our approach shows that noninvasive prenatal paternity testing can be performed within the first trimester with the use of a maternal blood sample," Guo and colleagues conclude.
Several authors are employees of Ravgen, which supported the study and holds patents and has patents pending for the methods described in the study.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top